Atossa Genetics Opens Enrollment in Study of Endoxifen

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
79
Atossa Genetics Opens Enrollment in Study of Endoxifen

SEATTLE, WA--(Marketwired - Mar 23, 2017) - Atossa Genetics Inc. ( NASDAQ : ATOS ) today announced that it has opened enrollment of a Phase 1 study of endoxifen, which is an active metabolite of tamoxifen, an FDA approved drug for breast cancer. The objectives of this placebo-controlled, repeat dose study of 48 healthy female volunteers is to assess the pharmacokinetics of proprietary formulations of both oral and topical endoxifen dosage forms over 28 days, as well as to assess safety and tolerability.

The study is being conducted on behalf of Atossa by CPR Pharma Services Pty Ltd., Thebarton, SA, Australia. 

About Atossa Genetics

Atossa Genetics Inc., is a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions. For more information, please visit www.atossagenetics.com .

Forward-Looking Statements

Forward-looking statements in this press release, which Atossa undertakes no obligation to update, are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions and inactions by the FDA, the outcome or timing of regulatory approvals needed by Atossa, lower than anticipated rate of patient enrollment, results of clinical studies, the safety and efficacy of Atossa's products and services, performance of clinical research organizations and investigators, obstacles resulting from proprietary rights held by others with respect to fulvestrant, such as patent rights, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time.

Atossa Genetics Company Contact: Atossa Genetics Inc. Kyle Guse CFO and General Counsel (O) 800-351-3902 kyle.guse@atossagenetics.com Investor Relations Contact: Scott Gordon CoreIR 377 Oak Street Concourse 2 Garden City, NY 11530 Office: 516.222.2560 scottg@CoreIR.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 5

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 7

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 4

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 6

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 9

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Equity 1031 Exchange Launches Innovative Referral Incentives

Updated Category News Views 189

Equity 1031 Exchange Launches Referral Incentive Program In a dynamic real estate market, Equity 1031 Exchange has stepped forward to empower real estate professionals by introducing an exciting referral program. This innovative initiative rewards agents and brokers with a cash incentive of $225 for each valid referral. This program is designed to enhance connections...

Continue Reading
Man Group PLC Expands Influence: Recent Disclosures Overview

Updated Category News Views 190

Understanding Man Group PLC's Recent Disclosure Man Group PLC has been active in the financial markets, particularly through its engagement with Spirent Communications PLC. This disclosure offers insight into the key financial positions and interests held by Man Group PLC, touching on their significant stake within relevant securities. Key Information About the Disclosure...

Continue Reading
Revolutionary Rescue Link Boosts Patient Compliance for Eye Care

Updated Category News Views 163

Revolutionary Rescue Link Launch by DryEye Rescue DryEye Rescue has introduced a remarkable tool called Rescue Link, aimed at transforming how eye care professionals engage with their patients. This innovative platform allows providers to send personalized over-the-counter (OTC) product recommendations via text within 60 seconds, ensuring that patients receive the precise...

Continue Reading
Lundbeck's Vyepti Gets Green Light in South Korea

Updated Category News Views 8

A New Dawn for Migraine Treatment in South Korea Well, if there’s anything investors and healthcare watchers should keep an eye on, it's today’s news from H. Lundbeck A/S. This Danish biopharma powerhouse just scored an important win—South Korea’s Ministry of Food and Drug Safety (MFDS) approved their migraine treatment, Vyepti (eptinezumab). It’s a big step for...

Continue Reading
What Are The New Paths to Financial Freedom in 2025?

Updated Category Crypto Views 872

The new dream of the modern residents of Gila Valley seems easy. Ditch the 9-to-5, and travel the world, while having enough money in the bank. The good news is that, in 2025, there are many ways to break free from financial stress. With technology and the right financial tools, it is easier to invest smarter and have more opportunities to control wealth without stress....

Continue Reading